|
| |
| Olga Rozanova |
| |
| ''The role of the government's participation constraint in the relationship between the price of the medicine and the patients' co-payment'' |
| ( 2021, Vol. 41 No.3 ) |
| |
| |
| In the paper the relationship between the price of the drug set by the monopolist and the level of the patients' co-payment is reconsidered. I highlight the role of the government's participation constraint when studying this correspondence. I provide an alternative explanation for why the price of the pharmaceutical can be an increasing function of the level of the patients' co-payment. |
| |
| |
| Keywords: price of the pharmaceutical, co-payment, participation constraint of the payer |
JEL: D4 - Market Structure and Pricing: General
I1 - Health: General |
| |
| Manuscript Received : Feb 10 2021 | | Manuscript Accepted : Sep 17 2021 |
|
